Clinical application of serum Golgi protein 73 in patients with chronic liver diseases / 中华肝脏病杂志
Chinese Journal of Hepatology
;
(12): 4-8, 2022.
Article
Dans Chinois
| WPRIM
| ID: wpr-935903
ABSTRACT
Golgi protein 73 (GP73) is a transmembrane protein on the Golgi apparatus and can be cut and released into the blood. In recent years, an increasing number of clinical studies have shown that the elevated serum GP73 level is closely related to liver diseases. And thus GP73 is expected to be used as a new serum marker for assessing progress of chronic liver diseases. Herein, the clinical application of serum GP73 in chronic hepatitis, liver fibrosis, liver cirrhosis and hepatocellular carcinoma with different etiologies was reviewed based on available literatures; and a research outlook in this field is made.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Marqueurs biologiques
/
Carcinome hépatocellulaire
/
Appareil de Golgi
/
Cirrhose du foie
/
Tumeurs du foie
Limites du sujet:
Humains
langue:
Chinois
Texte intégral:
Chinese Journal of Hepatology
Année:
2022
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS